ZZ
Ziv Zwighaft
I'm working on
a month ago
Ambrosia Bio transforms low-value sugars into allulose, a rare and naturally occurring sugar, which is nearly chemically identical to sugar but with 10% of the calories, and no impact on blood sugar and insulin levels.
I'm looking for
6 months ago
€1.5m Pre-Series A planned to advance the technology to TRL 7 (running of a 5000kg p.a. pilot facility), obtaining full FDA clearance, and onboarding the first strategic partner. We are also looking forward to sponsored research and strategic collaborations.
About
We enable stable, cost-effective production supply. The most cost-effective allulose
production technology on the planet – less than 50% of current market prices at scale. Patented
enzyme, flexible deployment model, and an optimised bioprocess, designed with specialist
industry partners (Seprosys and Applexion). Ability to meet and exceed current purity and
crystallisation requirements of the industry.
Partnering listings
Learn more
Ambrosia Bio Ltd.
Enzymatic production of d-allulose as a low-calorie functional sugar for healthy weight management
D-allulose is a functional low-calorie sugar delivering the taste of sucrose with approximately 90% fewer calories and minimal glycemic impact. Ambrosia Bio's proprietary enzymatic platform enables cost-efficient, scalab...
TechnologyIn marketCompany
Ambrosia Bio Ltd.
Funding or sponsored research
What we have achieved to date: (i) Benchmark Ambrosia’s proprietary technology in an industry-relevant environment (TRL6) – demonstrate and quantify the technological advantage. This has been challenged and confirmed by ...
TechnologyIn developmentCompany
Partner smarter. Move faster.
Get new partnering requests
delivered to your inbox.
delivered to your inbox.
© 2026 Halo Cures, Inc.